{
    "nctId": "NCT00586898",
    "title": "Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "or",
                "operands": [
                    {
                        "type": "and",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "history of localized disease"
                            },
                            {
                                "type": "variable",
                                "value": "undergone definitive radiation or surgery"
                            },
                            {
                                "type": "variable",
                                "value": "progression of disease biochemically"
                            },
                            {
                                "type": "not",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "radiographically evident disease"
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "and",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "radiographic evidence of metastatic disease"
                            },
                            {
                                "type": "or",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "newly detected disease"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "progressing disease in bone or in soft tissue"
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            {
                "type": "variable",
                "value": "Diagnosis of prostate adenocarcinoma histologically confirmed at MSKCC"
            },
            {
                "type": "variable",
                "value": "level of serum testosterone above the lower limit of normal"
            },
            {
                "type": "variable",
                "value": "Karnofsky performance status (KPS) > 70%"
            },
            {
                "type": "variable",
                "value": "WBC > 3500/mm3"
            },
            {
                "type": "variable",
                "value": "platelet count > 100,000/mm3"
            },
            {
                "type": "or",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Bilirubin < 2.0 mg/dl"
                    },
                    {
                        "type": "variable",
                        "value": "SGOT < 3.0 X the upper limit of normal"
                    }
                ]
            },
            {
                "type": "or",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Creatinine < 1.6 mg/dl"
                    },
                    {
                        "type": "variable",
                        "value": "creatinine clearance > 60 cc/min"
                    }
                ]
            },
            {
                "type": "or",
                "operands": [
                    {
                        "type": "and",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Neoadjuvant treatment prior to radiation therapy or radical prostatectomy"
                            },
                            {
                                "type": "variable",
                                "value": "total duration of exposure does not exceed 10 months"
                            }
                        ]
                    },
                    {
                        "type": "and",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "One cycle of intermittent therapy"
                            },
                            {
                                "type": "variable",
                                "value": "maximum exposure of 10 months"
                            }
                        ]
                    }
                ]
            },
            {
                "type": "variable",
                "value": "Patients must be at least 18 years of age"
            },
            {
                "type": "variable",
                "value": "Patients must have signed an informed consent document"
            },
            {
                "type": "variable",
                "value": "Must be MALE"
            },
            {
                "type": "variable",
                "value": "Must have minimum age of 18 Years"
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Clinically significant cardiac disease (New York Heart Association Class III/IV)"
                            },
                            {
                                "type": "variable",
                                "value": "severe debilitating pulmonary disease"
                            },
                            {
                                "type": "variable",
                                "value": "Uncontrolled serious active infection"
                            },
                            {
                                "type": "variable",
                                "value": "Anticipated survival of less than 3 months"
                            },
                            {
                                "type": "variable",
                                "value": "Active CNS or epidural tumor"
                            },
                            {
                                "type": "variable",
                                "value": "Inability or unwillingness to comply with the treatment protocol, follow-up, or research tests"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('Diagnosis of prostate adenocarcinoma histologically confirmed at MSKCC'), Symbol('Karnofsky performance status (KPS) > 70%'), Symbol('Must be MALE'), Symbol('Must have minimum age of 18 Years'), Symbol('Patients must be at least 18 years of age'), Symbol('Patients must have signed an informed consent document'), Symbol('WBC > 3500/mm3'), Symbol('level of serum testosterone above the lower limit of normal'), Symbol('platelet count > 100,000/mm3'), Or(Symbol('Bilirubin < 2.0 mg/dl'), Symbol('SGOT < 3.0 X the upper limit of normal')), Or(Symbol('Creatinine < 1.6 mg/dl'), Symbol('creatinine clearance > 60 cc/min')), Or(And(Symbol('Neoadjuvant treatment prior to radiation therapy or radical prostatectomy'), Symbol('total duration of exposure does not exceed 10 months')), And(Symbol('One cycle of intermittent therapy'), Symbol('maximum exposure of 10 months'))), Not(Or(Symbol('Active CNS or epidural tumor'), Symbol('Anticipated survival of less than 3 months'), Symbol('Clinically significant cardiac disease (New York Heart Association Class III/IV)'), Symbol('Inability or unwillingness to comply with the treatment protocol, follow-up, or research tests'), Symbol('Uncontrolled serious active infection'), Symbol('severe debilitating pulmonary disease'))), Or(And(Symbol('radiographic evidence of metastatic disease'), Or(Symbol('newly detected disease'), Symbol('progressing disease in bone or in soft tissue'))), And(Symbol('history of localized disease'), Symbol('progression of disease biochemically'), Symbol('undergone definitive radiation or surgery'), Not(Symbol('radiographically evident disease')))))"
}